Barry Fishman

Barry Fishman is the Chief Corporate Development Officer at Apotex Inc., which is planning a $1-billion IPO. With a strong background in corporate strategy and development from his previous roles, Fishman plays a crucial part in Apotex's growth and commitment to expanding its offerings in the pharmaceutical market.